Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SMTI - Sanara MedTech Inc.

IEX Last Trade
35.09
0.550   1.567%

Share volume: 0
Last Updated: Thu 26 Dec 2024 03:28:38 PM CET

PREVIOUS CLOSE
CHG
CHG%
$34.54
0.55
1.59%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Performance
5 Days
3.74%
1 Month
-7.32%
3 Months
20.40%
6 Months
23.99%
1 Year
-8.70%
2 Year
-21.47%
Key data
Stock price
$35.09
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$27.55 - $43.25
52 WEEK CHANGE
-$15.38
MARKET CAP 
313.929 M
YIELD 
N/A
SHARES OUTSTANDING 
8.747 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
BETA 
2.02
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$35,531
AVERAGE 30 VOLUME 
$34,293
Company detail
CEO: Zachary B. Fleming
Region: US
Website: sanaramedtech.com
Employees: 60
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel for the management of full and partial thickness wounds.

Recent news